相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Recurrence of disease activity during pregnancy after cessation of fingolimod in multiple sclerosis
Ingrid Meinl et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Recurrence of disease activity during pregnancy after cessation of fingolimod in multiple sclerosis
Ingrid Meinl et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks
Emilio Portaccio et al.
NEUROLOGY (2018)
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks
Emilio Portaccio et al.
NEUROLOGY (2018)
The role of the placenta in drug transport and fetal drug exposure
Gideon Koren et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2018)
Neonatal pancytopenia in a child, born after maternal exposure to natalizumab throughout pregnancy
L. Guilloton et al.
JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION (2017)
Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study
Susan Friend et al.
BMC NEUROLOGY (2016)
Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning
Vittorio Martinelli et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning
Vittorio Martinelli et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Natalizumab discontinuation and disease restart in pregnancy: a case series
L. De Giglio et al.
ACTA NEUROLOGICA SCANDINAVICA (2015)
Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study
Neda Ebrahimi et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Normal outcome of pregnancy with ongoing treatment with natalizumab
J. Fagius et al.
ACTA NEUROLOGICA SCANDINAVICA (2014)
Epidemiology of loss pregnancy
A. Delabaere et al.
JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION (2014)
Natalizumab Use During the Third trimester of Pregnancy
Aiden Haghikia et al.
JAMA NEUROLOGY (2014)
Natalizumab treatment during pregnancy - effects on the neonatal immune system
H. Schneider et al.
ACTA NEUROLOGICA SCANDINAVICA (2013)
Delivery of healthy babies after natalizumab use for multiple sclerosis: a report of two cases
I. A. Hoevenaren et al.
ACTA NEUROLOGICA SCANDINAVICA (2011)
Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment
Kerstin Hellwig et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Embryo/Fetal Development in Cynomolgus Monkeys Exposed to Natalizumab, an α4 Integrin Inhibitor
Nancy G. Wehner et al.
BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY (2009)
Effects of Natalizumab, an α4 Integrin Inhibitor, on the Development of Hartley Guinea Pigs
Nancy G. Wehner et al.
BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY (2009)
Audipog perinatal network. Part 1: Principal perinatal health indicators, 2004-2005
F. Vendittelli et al.
GYNECOLOGIE OBSTETRIQUE & FERTILITE (2008)
A prospective longitudinal population-based study of clinical miscarriage in an urban Swedish population
F. Blohm et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2008)
Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse
S Vukusic et al.
BRAIN (2004)
分享论文
